Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox renal hemodynamics study in adults with beta-thalassemia and transfusional iron overload
2006-006838-17Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of deferasirox in beta thalassemia and iron overload, sponsored by Novartis. Primary endpoints: Absolute change from baseline in glomerular filtration rate, Absolute change from baseline in renal plasma flow and 1 more. Started Jul 2007; status: terminated.
02
Drugs
deferasirox
03
Conditions
beta thalassemiairon overload
Beyond the preview
Go deeper on 2006-006838-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006838-17.